ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993

In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA

June 30, 1995

Senators Urge study section On Clinical Cancer Research

February 4, 1994

More Oncopathology Research Asked

June 30, 1978

In Brief: Beatrice Mintz Appointed to Pontifical Academy; Three Americans Asked to Help Shanghai Group

November 28, 1986

DCPC board Oks New Grant Program For Investigators

March 4, 1994